Royal Capital Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Royal Capital Wealth Management, LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $12.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$12.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 3,865 | $3.6M |
| JNJJOHNSON & JOHNSON | 8,323 | $2.0M |
| ABBVAbbVie Inc. | 8,831 | $1.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,224 | $1.7M |
| AMGNAMGEN INC | 2,774 | $976K |
| PMPhilip Morris International Inc | 3,572 | $591K |
| GMOptec International, Inc. | 5,887 | $439K |
| CAHCardinal Health Inc. | 1,912 | $404K |
| ABTABBOTT LABORATORIES | 3,583 | $368K |
| NVSNovartis AG | 1,394 | $213K |
| CRMDCorMedix Inc. | 28,500 | $194K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.